Drug Pipeline

Riluzole Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
4
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-10 NCT07142291
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS		 date change Primary completion moved earlier: 2027-11 -> 2027-03
2026-06-10 NCT07142291
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS		 date change Completion moved earlier: 2028-03 -> 2027-06
Active Studies by Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07447050 Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot… Breast Cancer Recruiting
NCT07142291 PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALS Amyotrophic Lateral Sclerosis (ALS) Recruiting
Phase 1/2
NCT07414212 Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole… Amyotrophic Lateral Sclerosis Recruiting
Phase 1
NCT01303341 Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or… Advanced Malignant Solid Neoplasm Active, Not Recruiting
Sponsors Running Riluzole Trials
National Cancer Institute (NCI) (1) PhenoNet, Inc. (1) Biogipuzkoa Health Research Institute (1) University of California, Irvine (1)
Disease Areas
ALS (2) Melanoma (1) Lung Cancer (1) Breast Cancer (1) Colorectal Cancer (1) Liver Cancer (1) Ovarian Cancer (1) Head & Neck Cancer (1) Sarcoma (1)
Get alerts when Riluzole trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free